Despite the massive global spend on biology-driven drug discovery, tackling the issue of side effects and adverse events resulting from drug promiscuity represents a persistent challenge. Although delivering authentic medical innovations today is more complex than ever, minimization of off-target effects should be a priority.

中文翻译：

---

选择性治疗干预：针对脱靶效应的挑战

尽管全球在生物驱动的药物发现上投入了大量资金，但解决因滥交造成的副作用和不良事件仍然是一项持续的挑战。尽管今天提供可靠的医学创新比以往任何时候都更为复杂，但将脱靶效应降至最低仍是当务之急。